Optimized antisense oligonucleotides complementary to DNA methyltransferase sequences
US6506735B1 · kind B1 · utility
4Cited by
3References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 22, 2000 |
| Grant date | Jan 14, 2003 |
| Priority date | — |
| Expiry date | May 22, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/346
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides optimized antisense oligonucleotides complementary to the DNA methyltransferase gene or its RNA transcript. The invention further provides methods for using such antisense oligonucleotides as analytical and diagnostic tools, as potentiators of transgenic plant and animal studies and gene therapy approaches, and as potential therapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.